Recent Advances in Antigen-Specific Immunotherapies for the Treatment of Multiple Sclerosis

Multiple sclerosis (MS) is an autoimmune disease of the central nervous system and is considered to be the leading non-traumatic cause of neurological disability in young adults. Current treatments for MS comprise long-term immunosuppressant drugs and disease-modifying therapies (DMTs) designed to a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kammona, Olga, Kiparissides, Costas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348736/
https://www.ncbi.nlm.nih.gov/pubmed/32486045
http://dx.doi.org/10.3390/brainsci10060333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348736/
https://www.ncbi.nlm.nih.gov/pubmed/32486045
http://dx.doi.org/10.3390/brainsci10060333

Ejemplares similares